RVNC Historical Earnings image   This RVNC historical earnings page last updated 8/11/2022
RVNC Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/9/20220.03B
Q1 20225/10/20220.03B
Q4 20212/28/20220.03B
Q3 202111/9/20210.02B
Q2 20218/5/20210.02B
Q1 20215/10/20210.01B
Q4 20202/22/20210.01B
Q3 202011/9/20200.00B
Q2 20208/6/20200.00B
Q1 20205/7/20200.06M
Q4 20192/24/20200.09M
Q3 201911/4/20190.05M
Q2 20198/5/2019NA
Q1 20195/8/20190.00B
Q4 20182/26/2019487000
Q3 201811/1/20182.36M
Q2 20188/2/2018686000
Q1 20185/8/2018193000
Q4 20172/28/201837000
Q3 201711/2/201775000
Q2 20178/3/201775000
Q1 20175/9/201775000
Q4 20162/27/201775000
Q3 201611/3/201675000
Q2 20168/4/201675000
Q1 20165/9/201675000
Q4 20153/2/201675000
Q3 201511/9/201575000
Q2 20158/6/201575000
Q1 20155/13/201575000
Q4 20143/2/201575000
Q3 201411/12/201480000
Q2 20148/12/201475000
Q1 20145/13/2014158000
Q4 20133/26/2014309000
RVNC Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/9/2022-0.880
Q1 20225/10/2022-0.940
Q4 20212/28/2022-0.930
Q3 202111/9/2021-1.100
Q2 20218/5/2021-1.070
Q1 20215/10/2021-1.080
Q4 20202/22/2021-1.240
Q3 202011/9/2020-1.340
Q2 20208/6/2020-1.120
Q1 20205/7/2020-1.150
Q4 20192/24/2020-0.990
Q3 201911/4/2019-0.960
Q2 20198/5/2019-0.860
Q1 20195/8/2019-0.850
Q4 20182/26/2019-1.12
Q3 201811/1/2018-0.91
Q2 20188/2/2018-0.94
Q1 20185/8/2018-0.97
Q4 20172/28/2018-1.04
Q3 201711/2/2017-1.01
Q2 20178/3/2017-0.9
Q1 20175/9/2017-0.94
Q4 20162/27/2017-0.95
Q3 201611/3/2016-0.64
Q2 20168/4/2016-0.88
Q1 20165/9/2016-0.71
Q4 20153/2/2016-0.83
Q3 201511/9/2015-0.81
Q2 20158/6/2015-0.71
Q1 20155/13/2015-0.65
Q4 20143/2/2015-0.6
Q3 201411/12/2014-0.72
Q2 20148/12/2014-0.69
Q1 20145/13/2014-1.93
Q4 20133/26/2014-47.11
Quotes delayed 20 minutes

Email EnvelopeFree RVNC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Revance Therapeutics (RVNC) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

RVPH Historical Earnings
RXDX Historical Earnings
RXRX Historical Earnings
RXST Historical Earnings
RYTM Historical Earnings
RZLT Historical Earnings
SAGE Historical Earnings
SANA Historical Earnings
SAVA Historical Earnings
SBTX Historical Earnings
What was the record high RVNC historical earnings result?
In terms of earnings or revenue, what is the best RVNC historical earnings result that Revance Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest RVNC historical earnings result was set in Q4 2014, when Revance Therapeutics posted results of -0.6/share. The most successful revenue quarter within our data set was Q2 2022 when Revance Therapeutics reported revenue of 0.03B.

What was the lowest Revance Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest RVNC has reported, and when?

✔️Accepted answer: Within our data set, the lowest RVNC historical earnings result was set in Q4 2013, when Revance Therapeutics posted results of -47.11/share. The smallest revenue quarter within our data set was Q2 2019 when Revance Therapeutics reported revenue of NA.

On this page we presented the RVNC historical earnings date information for Revance Therapeutics. Reviewing that RVNC Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2014, when RVNC posted gaap of -0.6/share. Meanwhile the lowest RVNC historical earnings result was in Q4 2013, when RVNC posted gaap of -47.11/share. Moving to Revance Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when RVNC reported 0.03B in revenue, while the smallest revenue quarter was Q2 2019 when RVNC reported NA in revenue.

For self directed investors doing their due diligence on RVNC or any other given stock, their research can benefit from looking into all of the Revance Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Revance Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for RVNC. Thanks for visiting, and the next time you need to research RVNC historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: FBSS YTD Return, HEZU Videos, Top Ten Hedge Funds Holding IWC.

 

RVNC Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.